Icure Pharmaceutical Incorporation (175250) — Long-term Investment Intensity
Icure Pharmaceutical Incorporation (175250) has a Long-term Investment Intensity of 5.7% as of December 2019. Long-term investments of ₩12.24 Billion represent 5.7% of total assets of ₩215.80 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Icure Pharmaceutical Incorporation to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Icure Pharmaceutical Incorporation Long-term Investment Intensity (2015–2019)
This chart shows how Icure Pharmaceutical Incorporation's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 5.7%, reflecting long-term investments of ₩12.24 Billion against total assets of ₩215.80 Billion KRW. For the complete balance sheet picture, see 175250 total asset value.
Annual Long-term Investment Intensity for Icure Pharmaceutical Incorporation (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for Icure Pharmaceutical Incorporation from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Icure Pharmaceutical Incorporation for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 5.7% | ₩12.24 Billion | ₩215.80 Billion | ▼ -4.2 pp |
| 2018 | 9.8% | ₩11.89 Billion | ₩121.00 Billion | ▲ +7.5 pp |
| 2017 | 2.4% | ₩1.27 Billion | ₩53.90 Billion | ▼ -0.1 pp |
| 2016 | 2.4% | ₩771.33 Million | ₩31.53 Billion | ▲ +1.3 pp |
| 2015 | 1.2% | ₩306.69 Million | ₩26.15 Billion | — |